PDCD1 and small cell lung carcinoma: Our findings showed the prognostic value of pretreatment LIPI in advanced SCLC patients receiving first-line ICI treatment combined with chemotherapy, especially in males, those with ED, those receiving PD-1 inhibitor treatment, smokers, and those with liver metastasis.